Therapeutic application of PPE2 protein of Mycobacterium tuberculosis in inhibiting tissue inflammation

Document Type

Article

Publication Title

EMBO Molecular Medicine

Abstract

There is an increasing need to develop biological anti-inflammatory agents that are more targeted, effective, and with lesser side effects as compared to conventional chemical drugs. In the present study, we found that Mycobacterium tuberculosis protein PPE2 and a synthetic derivative peptide can suppress the mast cell population and inhibit several vasoactive and fibrogenic mediators and pro-inflammatory cytokines induced by mast cells in formalin-induced tissue injury. PPE2 was found to inhibit transcription from the promoter of stem cell factor, important for mast cell maintenance and migration. Thus, PPE2/peptide can be used as a potent nonsteroidal therapeutic agent for the treatment of inflammation and tissue injury.

DOI

10.15252/emmm.202114891

Publication Date

9-7-2022

This document is currently not available here.

Share

COinS